204 related articles for article (PubMed ID: 38690020)
1. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?
de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020
[TBL] [Abstract][Full Text] [Related]
2. The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel disease.
Ghafouri-Fard S; Eghtedarian R; Taheri M
Biomed Pharmacother; 2020 Sep; 129():110507. PubMed ID: 32768980
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.
Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337
[TBL] [Abstract][Full Text] [Related]
4. Role of MiRNAs in Inflammatory Bowel Disease.
Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
[TBL] [Abstract][Full Text] [Related]
5. Trefoil factors in inflammatory bowel disease.
Aamann L; Vestergaard EM; Grønbæk H
World J Gastroenterol; 2014 Mar; 20(12):3223-30. PubMed ID: 24696606
[TBL] [Abstract][Full Text] [Related]
6. Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease.
Fu SH; Chien MW; Hsu CY; Liu YW; Sytwu HK
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403220
[TBL] [Abstract][Full Text] [Related]
7. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?
Aggeletopoulou I; Mouzaki A; Thomopoulos K; Triantos C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768556
[TBL] [Abstract][Full Text] [Related]
8. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis.
Granlund Av; Flatberg A; Østvik AE; Drozdov I; Gustafsson BI; Kidd M; Beisvag V; Torp SH; Waldum HL; Martinsen TC; Damås JK; Espevik T; Sandvik AK
PLoS One; 2013; 8(2):e56818. PubMed ID: 23468882
[TBL] [Abstract][Full Text] [Related]
9. Epithelial expression of interleukin-37b in inflammatory bowel disease.
Imaeda H; Takahashi K; Fujimoto T; Kasumi E; Ban H; Bamba S; Sonoda H; Shimizu T; Fujiyama Y; Andoh A
Clin Exp Immunol; 2013 Jun; 172(3):410-6. PubMed ID: 23600829
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
[TBL] [Abstract][Full Text] [Related]
11. miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells.
Chen Y; Xiao Y; Ge W; Zhou K; Wen J; Yan W; Wang Y; Wang B; Qu C; Wu J; Xu L; Cai W
Cell Death Dis; 2013 Mar; 4(3):e541. PubMed ID: 23492772
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future.
Oliveira ECS; Quaglio AEV; Magro DO; Di Stasi LC; Sassaki LY
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108339
[TBL] [Abstract][Full Text] [Related]
13. Roles of microRNAs in inflammatory bowel disease.
Jung H; Kim JS; Lee KH; Tizaoui K; Terrazzino S; Cargnin S; Smith L; Koyanagi A; Jacob L; Li H; Hong SH; Yon DK; Lee SW; Kim MS; Wasuwanich P; Karnsakul W; Shin JI; Kronbichler A
Int J Biol Sci; 2021; 17(8):2112-2123. PubMed ID: 34131410
[TBL] [Abstract][Full Text] [Related]
14. Proteomic insights on the metabolism in inflammatory bowel disease.
Pisani LF; Moriggi M; Gelfi C; Vecchi M; Pastorelli L
World J Gastroenterol; 2020 Feb; 26(7):696-705. PubMed ID: 32116417
[TBL] [Abstract][Full Text] [Related]
15. Differential Gene Expression Profiles Involved in the Inflammations Due to COVID-19 and Inflammatory Bowel Diseases and the Investigation of Predictive Biomarkers.
Aishwarya S; Gunasekaran K
Biochem Genet; 2024 Feb; 62(1):311-332. PubMed ID: 37335372
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
17. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.
Xu XM; Zhang HJ
World J Gastroenterol; 2016 Feb; 22(7):2206-18. PubMed ID: 26900285
[TBL] [Abstract][Full Text] [Related]
18. Highly Multiplexed Image Analysis of Intestinal Tissue Sections in Patients With Inflammatory Bowel Disease.
Kondo A; Ma S; Lee MYY; Ortiz V; Traum D; Schug J; Wilkins B; Terry NA; Lee H; Kaestner KH
Gastroenterology; 2021 Dec; 161(6):1940-1952. PubMed ID: 34529988
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of microRNAs of the miR-200 family and up-regulation of Snail and Slug in inflammatory bowel diseases - hallmark of epithelial-mesenchymal transition.
Zidar N; Boštjančič E; Jerala M; Kojc N; Drobne D; Štabuc B; Glavač D
J Cell Mol Med; 2016 Oct; 20(10):1813-20. PubMed ID: 27113480
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.
Quaglio AEV; Santaella FJ; Rodrigues MAM; Sassaki LY; Di Stasi LC
World J Gastroenterol; 2021 Dec; 27(45):7801-7812. PubMed ID: 34963743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
